A Study of SBT6050 in Patients With Advanced HER2 Expressing Solid Tumors

Condition:   HER2 Positive Solid Tumors Intervention:   Drug: SBT6050 Sponsor:   Silverback Therapeutics Not yet recruiting

Source: ClinicalTrials.gov - July 7, 2020 Category: Research Source Type: clinical trials